Clinical Trial Update: A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2, single-center prospective study evaluating surufatinib in combination with AG regimen as first-line therapy for locally advanced or metastati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: Fudan University | Conditions: Pancreatic Cancer Metastatic | Phase 2 | Status: RECRUITING